Innovex International, Inc. vs NOV Inc. — Valuation Comparison 2026
Access all valuation models for INVX vs NOV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →INVX scores higher with a 9.4/10 quality rating vs NOV's 8.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Innovex International, Inc. (INVX) and NOV Inc. (NOV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
INVX currently trades at $26.71 with a QOC of 9.4/10, while NOV trades at $19.96 with a QOC of 8.1/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).